Clinical Trial Update: Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase II exploratory study of toripalimab in combination with SBRT for HER2-negative breast cancer patients who are insensitive to neoadjuvant chemotherapy; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING